.png)
The Cardiac
Biomarkers Market is expected to reach a value of USD 13,370 million in
2023. With a linear growth pattern, it is predicted to reach a value of USD
38,000 million by 2033, growing at a compound annual growth rate of 11% between
2024 - 2033.
Protein molecules known as cardiac biomarkers are discharged
into the bloodstream during heart attack or severe cardiac strain. These
indicators serve as possible diagnostic tools for a number of cardiovascular
illnesses (CVD), including congestive heart failure, myocardial infarction,
acute coronary syndrome, and cardiac ischemia. Cardiac biomarker testing are
the test used to assess the risk and health of patients associated with such
diseases.
Tests for cardiac biomarkers are carried out when a patient
experiences chest pain. Cardiovascular disease screening tests use troponin,
creatine kinase-muscle/brain (CK-MB), B-type natriuretic peptide (BNP), and
high-sensitivity C-reactive protein (hs-CRP) as cardiac biomarkers. The cardiac
biomarkers that are frequently used as an integrated diagnostic approach for
cardiovascular diseases include myoglobin, brain natriuretic peptide (BNPs),
ischemia modified albumin (IMA), cardiac muscle creatine kinase (CK-MB),
troponin I and T, and myoglobin. This creates a more favorable environment for
the overall growth of the cardiac biomarker market.
Sample
Report Available at Your Request: https://wemarketresearch.com/sample-request/cardiac-biomarker-market/1306
One major trend that is becoming more and more popular in
the cardiac biomarker market is technological improvement.To maintain their
market position, companies in the cardiac biomarker industry are using
innovative technologies.
Market Dynamics
Numerous factors, including the growing prevalence of
cardiovascular disorders, rising R&D spending, and advancements in cardiac
biomarker technology, are driving the cardiac biomarker market. For example,
data from the British Heart Foundation released in January 2022 stated that,
worldwide in 2021, ischemic heart disease, peripheral arterial (vascular)
disease, stroke, and atrial fibrillation accounted for 110 million, 100
million, and 60 million of all heart conditions affected.
Cardiac Biomarker Market Segmental Analysis –
By Type
·
Troponin
·
CK-MB
·
Myoglobin
·
BNP and NT-proBNP
By Application
·
Acute Coronary Syndrome
·
Myocardial Infarction
By End-User
·
Hospital
·
speciality Clinics
Country Scope
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux;
Nordic Countries; Russia; China; India; Japan; South Korea; Australia;
Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South
Africa; Nigeria
Cardiac Biomarker Market
Competitive
Outlook
F.
Hoffmann-La Roche AG, Abbott, Siemens AG, Creative Diagnostics, Beckman
Coulter, Inc., Thermo Fisher Scientific Inc., bioMérieux SA Others
Click here
for a more detailed explanation: https://wemarketresearch.com/purchase/cardiac-biomarker-market/1306?license=single
Frequently Asked Questions
1.
What is the market size of Cardiac Biomarker
market in 2022?
2.
Which are the top companies operating within
the market?
3.
Which region dominates the Cardiac Biomarker
market?
4.
What
is the Merger & Acquisition, New Product Launch, Recent Development within
each of the Markets?
About We
Market Research:
WE MARKET RESEARCH is an established market analytics and research
firm with a domain experience sprawling across different industries. We have
been working on multi-county market studies right from our inception. Over the
time, from our existence, we have gained laurels for our deep rooted market
studies and insightful analysis of different markets.
Our strategic market analysis and capability to comprehend deep
cultural, conceptual and social aspects of various tangled markets has helped
us make a mark for ourselves in the industry. WE MARKET RESEARCH is a
frontrunner in helping numerous companies; both regional and international to
successfully achieve their business goals based on our in-depth market
analysis. Moreover, we are also capable of devising market strategies that
ensure guaranteed customer bases for our clients.
Contact Us:
Mr. Robbin Joseph
Corporate Sales, USA
We Market Research
USA: +1-724-618-3925
Websites: https://wemarketresearch.com/
Email: sales@wemarketresearch.com
Related Articles:
Comments
Post a Comment